Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes (Q43999956)

From Wikidata
Jump to navigation Jump to search
scientific article published in May 2002
edit
Language Label Description Also known as
English
Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes
scientific article published in May 2002

    Statements

    Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes (English)
    CDC Diabetes Cost-effectiveness Group
    2542-2551

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit